Nafamostat Mesylate
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Nafamostat Mesylate, covering 2013-02-20 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury [Phase 4]